Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancerTakahiro Einama, Satoru Todo, Shigenori Homma et al.|British Journal of Cancer|2012Cited by 88
Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resectionKenji Wakayama, Akinobu Taketomi, Hirofumi Kamachi et al.|Journal of Surgical Oncology|2017Cited by 66
Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancerFutoshi Kawamata, Satoru Todo, Hirofumi Kamachi et al.|International Journal of Oncology|2012Cited by 60
C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinomaFutoshi Kawamata, Satoru Todo, Shigenori Homma et al.|Journal of Gastroenterology|2013Cited by 39
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse modelTatsuzo Mizukami, Akinobu Taketomi, Hirofumi Kamachi et al.|Oncotarget|2018Cited by 33